Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by 4real4everon Oct 01, 2021 2:21pm
111 Views
Post# 33953319

RE:ARISTOTLE and STAGEZERO

RE:ARISTOTLE and STAGEZERO

So much time wasted.

Same CEO. Same product. Same director. Same bla,bla,bla

In Stock Market "example", "maybe", "he can", "he say", "will", "should" doesn't work newbie. The reason for the $0,37 share price.

 

Only money, revenue, income and REAL deal with REAL companies works. **Take advices for your future**






Photoman77 wrote: SZLS has a new focus and direction. I for one have not lost any money as I have purchased most fo my shares at these price levels.

Aristotle has launched and the company is currently putting deals in place regarding partnerships (yes, bashers will come in now with company made this promise before. Difference is, the product was not launched but now it is so deals are in the works and i am sure we will see new releases soon on this regarding insurance and physician agreements)

SZLS has a new COO (Cheif Operation Officer) and CFO (Cheif Financial Officer) with a big pharma background in Astra Zeneca. He will push the product and company to new highs.

SZLS has direction with how to sell Aristotle. Although sales figures will factor in Q4 2021 and beyond, share price reflects that but these prices wont last once company starts to release financials that include Aristotle sales and cross sales from Care Oncology treatment plan sales) 

Example: 50 Aristotle tests per day at $1500 USD equates to $2.2 million dollars ($2.8 million CAD) per month in revenue.100 test is $4.4 million per month and so on. The demand for this type of test will only grow.

Aristole test results that show any cancer will be followed up by Care Oncology (Health CLinic Comapany that SZLS bought this summer) that can provide treatment options for patients which become cross sales for revenue. Average cost to treat cancer in US is between $20,000 to $100,000 per patient.

Average of almost 2 million new cancer diagnosis per year in the US and that number will only continue to grow. 

SZLS is poised to see exponential growth in this sector.

References:

https://www.cancer.gov/about-cancer/understanding/statistics

https://www.cnbc.com/2020/10/22/how-much-breast-cancer-treatment-costs-even-with-health-insurance-.html

https://careoncology.com/

https://www.stagezerolifesciences.com/

I am not a paid pumer, I am not a company employee, I am an investor set to make a ton of money with this company with the return on my investment.

 

<< Previous
Bullboard Posts
Next >>